Michael Potter (immunologist)
Michael Potter (1924–2013) was an American immunologist renowned for his pioneering research in the field of cancer and immunology. He made significant contributions to the understanding of plasma cell tumors and the genetics of antibody production.
Early Life and Education[edit | edit source]
Michael Potter was born in 1924. He pursued his undergraduate studies at Cornell University, where he developed an interest in biology. He later attended University of Virginia for his medical degree, graduating in 1949.
Career[edit | edit source]
Potter began his career at the National Institutes of Health (NIH) in the early 1950s. His work at the National Cancer Institute (NCI) focused on the study of plasma cell tumors in mice. This research was crucial in understanding the mechanisms of multiple myeloma, a type of blood cancer.
Research Contributions[edit | edit source]
Potter's research significantly advanced the field of immunology. He was instrumental in demonstrating the clonal nature of antibody-producing cells, which laid the groundwork for the monoclonal antibody technology. His work on the genetics of immunoglobulins provided insights into how the body produces a diverse array of antibodies.
Awards and Honors[edit | edit source]
Throughout his career, Michael Potter received numerous awards and honors, including the prestigious Albert Lasker Award for Basic Medical Research in 1984. He was also a member of the National Academy of Sciences and received the Paul Ehrlich and Ludwig Darmstaedter Prize.
Personal Life[edit | edit source]
Michael Potter was known for his dedication to science and his mentorship of young scientists. He passed away in 2013, leaving behind a legacy of significant scientific contributions.
Legacy[edit | edit source]
Potter's work continues to influence the fields of cancer research and immunology. His discoveries have paved the way for new treatments and therapies for various types of cancer and autoimmune diseases.
See Also[edit | edit source]
- Immunology
- Cancer research
- Monoclonal antibody
- National Institutes of Health
- National Cancer Institute
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
